US5756035A - Method of making an access graft and a vascular prosthesis - Google Patents
Method of making an access graft and a vascular prosthesis Download PDFInfo
- Publication number
- US5756035A US5756035A US08/655,317 US65531796A US5756035A US 5756035 A US5756035 A US 5756035A US 65531796 A US65531796 A US 65531796A US 5756035 A US5756035 A US 5756035A
- Authority
- US
- United States
- Prior art keywords
- tube
- core
- support member
- wet
- drying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
Definitions
- This invention concerns a vascular prosthesis adapted for use as an access graft, for example, for use in dialysis patients and also relates to molding an access graft, for example for use in dialysis patients and also relates to a method of making an access graft, for example for use by dialysis patients.
- vascular prosthesis adapted for use as an access graft which has a permanent set, kink-resistant U-shaped bent section.
- the U-shaped bent section is fashioned from a straight, flexible tubular graft which has been made for example by coagulation casting a bio-compatible polymer such as poly(ether)urethane and inserting a bend in the tube when wet, then drying the tube.
- the present invention provides a vascular prosthesis for use as an access graft which overcomes, to some extent, the problems aforesaid.
- vascular prosthesis adapted for use as an access graft which has a permanent set, kink-resistant U-shaped bent section.
- the cross-section of the prosthesis may be circular or may be non-circular.
- Examples of non-circular cross-sections for prostheses are tricuspid, epitrochoid and deltoid cross-sections.
- the vascular prosthesis may be arranged to be ⁇ self sealing ⁇ after multiple needle punctures.
- the prosthesis may be made of a heat degradable polymer and then drying is effected at a temperature which will not degrade the polymer. However, drying may clearly be carried out at temperatures up to 40° C. (blood heat) as polymers which will degrade at such temperatures are obviously unsuitable for implantation.
- a solution of coagulatable polymer may be dissolved in an organic solvent and may be coagulation cast onto a mandrel to make the prosthesis.
- the mandrel may have a circular cross-section, or a non-circular cross-section.
- non-circular cross-sections are tricuspid, eiptrochoid and deltoid cross-sections.
- the mandrel may be a pre-formed tube of PTFE and/or may be dip coated in the polymer solution.
- the polymer solution may, however, be extruded through an extrusion head onto the mandrel to more easily provide a prosthesis of uniform wall thickness.
- the polymer solution may contain a pore-forming agent soluble in a coagulant to leave a porous cast.
- the polymer may comprise polyurethane, and may be a linear segmented poly(ether)urethane with an average molecular weight in the region 20,000 to 60,000.
- the solvent may be aprotic, and may comprise N,N-dimethylacetamide or N,N-dimethylformamide.
- the concentration of the polymer in the solution may be between 10 and 30 grams/deciliter.
- the coagulant may comprise water.
- the present invention also provides a method by which high quality access grafts can be produced to standard dimensions.
- the invention comprises a method for making an access graft comprising a tube of implantable material adapted to be attached in a blood circulatory system and to provide thereby a site for access for cannulation, the tube having a permanent set, kink-resistant U-shaped bent section, the method comprising:
- the tube may, as before, be one that has been formed by coagulation coating on a former in the fashion described in WO 90/05628.
- the tube may be allowed to dry after forming and is then re-wet before the wrapping step. Alternatively, the tube can be taken to the wrapping step without ever being allowed to dry.
- the support member may be an easy sliding fit in the tube, but should be a reasonably snug fit--its purpose being to prevent kinking--consonant with insertion and removal--primarily insertion.
- the support member to ease insertion, is preferably of or is coated with a silicone or like substance that does not stick to the tube. If the tube is wet for the insertion of the support member, it is found to have a useful lubricating effect.
- the core may comprise a circular or near circular rod-like member having a diameter substantially the same as that of the tube--this provides an access graft of appropriate shape.
- the rod-like member may have helical fin means in which the tube is located. The eventual shape of the tube is found to depend on the extent of wrap and, for any particular material and configuration, it may be necessary to conduct a few trials with different extents of wrap necessary to produce the desired shape.
- an appropriately shaped graft will be produced if the tube is wrapped twice around the core.
- the wet tube wrapped on the core is constrained against movement (as by hanging weights on the protruding ends of the flexible support member) for drying--taking care not to deform the tube by excessive loading. Drying is preferably effected gently as by leaving the tube overnight in an oven at no more than 40° C.
- FIG. 1 shows a top view of the prosthesis of the invention
- FIGS. 2A-2C shows a cross-section of three types of the prosthesis shown in FIG. 1;
- FIGS. 3A-3C show a cross-section of three types of mandrels to produce the prostheses of FIGS. 2A-2C.
- FIG. 4 is a drawing showing the insertion of a flexible rod-like support member in a coagulation-cast tubular prosthesis
- FIG. 5 is an elevational view of a core on which the tube can be wrapped
- FIG. 6 is an elevational view showing the tube in place on the core.
- FIG. 7 is an elevational view of the resulting graft from the method of making an access graft.
- FIG. 1 shows a vascular prosthesis 20 adapted for use as an access graft having a permanent set, kink-resistant U-shaped bent section 21. As shown in FIG. 1, the section has a substantially constant cross-sectional shape throughout its length.
- FIGS. 2A-2C show three cross-sections of the prosthesis 20, a circular cross-section in FIG. 2A, a tricuspid epitrochoid cross-section in FIG. 2B and a deltoid cross-section in FIG. 2C.
- the prosthesis 20 may have a non-circular cross-section, whereof the lumen 22 will not totally occlude, thus further increasing the kink-resistance of prosthesis 20.
- the prosthesis 20 is made from a bio-compatible material, such as an elastomer, or a combination of elastomer and polytetrafluoroethylene (PTFE).
- a bio-compatible material such as an elastomer, or a combination of elastomer and polytetrafluoroethylene (PTFE).
- Preferred elastomers include polyurethane, polyurethaneurea, segmented polyurethanes and segmented polyurethaneureas. These materials give the prosthesis 20 the property of tending to be ⁇ self-sealing ⁇ after needle puncture, even after multiple needle punctures.
- the prosthesis 20 has a wall thickness and lumen size capable of withstanding multiple needle puncture by a large bore, i.e., 15 gauge needle used for dialysis treatment, while maintaining a compliance similar to that of natural vessels, overcoming the problem which at present prevents such thicker walled, small diameter conventional prostheses being used as access grafts.
- the prostheses 20, having a permanent set, kink-resistant U-shaped bent section 21 is made from a length of vascular prosthesis by coagulation casting a solution of coagulatable heat degradable polymer dissolved in an organic solvent onto a mandrel. Before allowing the casting to dry, or after re-wetting the casting after drying, a U-shaped bent section is formed in the prosthesis without introducing any kinks therein, and the prosthesis so formed is dried.
- the prosthesis 20 is dried in an oven at a temperature which will not degrade the polymer, usually up to 40° C.
- the U-shaped bent section 21 is formed in the length of prosthesis, after the introduction of an internal flexible former to prevent collapse of the lumen of the prosthesis on bending, either by drying over a shaped former, or by simply bending the length of prosthesis, having locating means to maintain the U-shaped bent section in position until dried. Once dried the internal flexible former is removed.
- a solution of coagulatable polymer such as a linear segmented polyetherurethane with an average weight of 20,000 to 60,000, is dissolved in a solution comprising an organic solvent, such as N,N-dimethylacetamide or N,N-dimethylformamide, at a concentration of polymer in a solution of between 20 and 30 grams/deciliter.
- an organic solvent such as N,N-dimethylacetamide or N,N-dimethylformamide
- the polymer solution contains a pore-forming agent, soluble in a coagulant to leave a porous cast, such as sodium hydrogen carbonate ground to an average particle size of 60 microns in an amount between 10 and 60 percent by weight.
- a pore-forming agent such as sodium hydrogen carbonate ground to an average particle size of 60 microns in an amount between 10 and 60 percent by weight.
- the polymer solution also contains a surfactant, such as sodium dodecyl sulphate, in an amount between 1 and 10 percent by weight.
- a surfactant such as sodium dodecyl sulphate
- a length of prosthesis is produced either by dip coating a mandrel in the polymer solution, or, to more easily produce a prosthesis having a uniform wall thickness, by extruding the polymer solution through an extrusion head as described in GB-A-2,204,873, the disclosure of which is incorporated herein by reference.
- the polymer-coated material is then immersed in a coagulant and allowed to coagulate.
- the preferred coagulant is water which is maintained at a constant temperature throughout the coagulation process, usually 40° C.
- the coagulation process normally takes 1 to 2 hours.
- FIGS. 3A-3C shows three examples of mandrels.
- Mandrel 23 has a circular cross-section and is used to produce the posthesis of FIG. 2A.
- Mandrel 24 has a tricuspid epitrochoid cross-section and is used to produce the prosthesis of FIG. 2B.
- Mandres 25 has a deltoid cross-section and is used to produce the prosthesis of FIG. 2C.
- FIGS. 4-7 illustrate a method for making an access graft 120 (FIG. 7) comprising a tube of implantable material such as a poly(ether)urethane made as described in WO 90/05628, the disclosure of which is incorporated herein by reference, adapted to be attached in a blood circulatory system and to provide thereby a site 121 for access to cannulation and the tube having a permanent set, kink-resistant U-bend section (the site 121), the method comprising:
- the tube 111 may be allowed to dry after being cast according to WO 90/05628 and may be processed dry up to an including its wrapping on the core 113, when it is wetted. However, if the manufacture of access grafts takes place reasonably close in time and space to the initial production of the tube 111, the later may be taken wet straight from the casting process and never allowed to dry up to and including it being wrapped on the core 113. It is found that the presence of water aids the insertion of the rod-like member 112 and a dry tube 111 might be wetted-out prior to such insertion.
- the member 112 should be a reasonably snug fit in the tube 111, but not such as to render threading-on too difficult. Being of or coated with silicone or like material helps insertion and removal.
- the core 113 comprises a circular or near circular rod-like member having a diameter substantially the same as that of the tube 111.
- the tube 111 After wrapping on the core 113 (either already wet, or dry, and then wetted-out) the tube 111 is placed in an oven overnight at 40° C. (not more, or at least not substantially more) to dry out so as to set the tube 111 so that, on removal from the core 113 and after retrieval of the support member 112, it constitutes a tube 120 with a U-shaped bent section 121.
- the wet (and drying) graft wrapped on the core 113 is constrained against movement by hanging weights 114 (or weighted clasps) whose weights are respectively not such as to cause deformation of the graft, and dried overnight at 40° C.
Landscapes
- Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/655,317 US5756035A (en) | 1991-08-01 | 1996-05-24 | Method of making an access graft and a vascular prosthesis |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9116563 | 1991-08-01 | ||
GB919116563A GB9116563D0 (en) | 1991-08-01 | 1991-08-01 | Vascular prosthesis ii |
WOPCT/GB92/01338 | 1992-07-21 | ||
PCT/GB1992/001338 WO1993002637A1 (en) | 1991-08-01 | 1992-07-21 | Vascular prosthesis |
US18215694A | 1994-04-29 | 1994-04-29 | |
US08/655,317 US5756035A (en) | 1991-08-01 | 1996-05-24 | Method of making an access graft and a vascular prosthesis |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US18215694A Continuation-In-Part | 1991-08-01 | 1994-04-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
US5756035A true US5756035A (en) | 1998-05-26 |
Family
ID=27265791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/655,317 Expired - Fee Related US5756035A (en) | 1991-08-01 | 1996-05-24 | Method of making an access graft and a vascular prosthesis |
Country Status (1)
Country | Link |
---|---|
US (1) | US5756035A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030062650A1 (en) * | 2000-10-03 | 2003-04-03 | Atrium Medical Corporation | Method for treating expandable polymer materials and products produced therefrom |
US20030120257A1 (en) * | 2001-11-20 | 2003-06-26 | Houston John Graeme | Method for introducing an internal helical formation into a flexible tubular material |
US20030176516A1 (en) * | 2002-03-15 | 2003-09-18 | Greene, Tweed Of Delaware, Inc. | Cellular perfluoroelastomeric compositions, sealing members, methods of making the same and cellular materials for medical applications |
WO2004037479A1 (en) | 2002-10-25 | 2004-05-06 | Medinol Ltd. | Mandrel and method for making stents |
US20040232587A1 (en) * | 2000-10-03 | 2004-11-25 | Atrium Medical Corp. | Method for forming expandable polymers having drugs or agents included therewith |
US20050075408A1 (en) * | 1994-05-13 | 2005-04-07 | Ringeisen Timothy A. | Method for making a porous polymeric material |
WO2006136861A1 (en) * | 2005-06-24 | 2006-12-28 | Veryan Medical Limited | Artificial graft tubing |
US20070106373A1 (en) * | 2003-07-04 | 2007-05-10 | Tayside Flow Technologies Limited | Internal formation for a conduit |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2964796A (en) * | 1955-12-15 | 1960-12-20 | Resistoflex Corp | Preformed flexible hose and method of making it |
JPS5551545A (en) * | 1978-10-11 | 1980-04-15 | Nikko Gomme Kogyo Kk | Method for manufacturing coil formed rubber tube |
US4257422A (en) * | 1979-03-14 | 1981-03-24 | Minnesota Mining And Manufacturing Company | Surgical drain |
US4345414A (en) * | 1978-11-20 | 1982-08-24 | Imperial Chemical Industries Limited | Shaping process |
WO1984002266A1 (en) * | 1982-12-13 | 1984-06-21 | Possis Medical Inc | Vascular graft and blood supply method |
WO1989001765A1 (en) * | 1987-08-28 | 1989-03-09 | Jarvik Robert K | Prosthetic compliance devices |
US4888074A (en) * | 1987-07-22 | 1989-12-19 | Dow Corning France S.A. | Therapeutic rings |
WO1991005522A1 (en) * | 1989-10-18 | 1991-05-02 | Newtec V.P. Limited | Polymer products |
US5132066A (en) * | 1987-04-09 | 1992-07-21 | Newtec V.P. Limited | Method of forming a bio-compatible vascular prosthesis |
-
1996
- 1996-05-24 US US08/655,317 patent/US5756035A/en not_active Expired - Fee Related
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2964796A (en) * | 1955-12-15 | 1960-12-20 | Resistoflex Corp | Preformed flexible hose and method of making it |
JPS5551545A (en) * | 1978-10-11 | 1980-04-15 | Nikko Gomme Kogyo Kk | Method for manufacturing coil formed rubber tube |
US4345414A (en) * | 1978-11-20 | 1982-08-24 | Imperial Chemical Industries Limited | Shaping process |
US4257422A (en) * | 1979-03-14 | 1981-03-24 | Minnesota Mining And Manufacturing Company | Surgical drain |
WO1984002266A1 (en) * | 1982-12-13 | 1984-06-21 | Possis Medical Inc | Vascular graft and blood supply method |
US4562597A (en) * | 1982-12-13 | 1986-01-07 | Possis Medical, Inc. | Method of supplying blood to blood receiving vessels |
US5132066A (en) * | 1987-04-09 | 1992-07-21 | Newtec V.P. Limited | Method of forming a bio-compatible vascular prosthesis |
US4888074A (en) * | 1987-07-22 | 1989-12-19 | Dow Corning France S.A. | Therapeutic rings |
WO1989001765A1 (en) * | 1987-08-28 | 1989-03-09 | Jarvik Robert K | Prosthetic compliance devices |
WO1991005522A1 (en) * | 1989-10-18 | 1991-05-02 | Newtec V.P. Limited | Polymer products |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8697108B2 (en) | 1994-05-13 | 2014-04-15 | Kensey Nash Corporation | Method for making a porous polymeric material |
US20050075408A1 (en) * | 1994-05-13 | 2005-04-07 | Ringeisen Timothy A. | Method for making a porous polymeric material |
US20040232587A1 (en) * | 2000-10-03 | 2004-11-25 | Atrium Medical Corp. | Method for forming expandable polymers having drugs or agents included therewith |
US6890463B2 (en) * | 2000-10-03 | 2005-05-10 | Atrium Medical Corporation | Method for treating expandable polymer materials |
US6923927B2 (en) * | 2000-10-03 | 2005-08-02 | Atrium Medical Corporation | Method for forming expandable polymers having drugs or agents included therewith |
US20030062650A1 (en) * | 2000-10-03 | 2003-04-03 | Atrium Medical Corporation | Method for treating expandable polymer materials and products produced therefrom |
US20080319536A1 (en) * | 2001-11-20 | 2008-12-25 | John Graeme Houston | Method for introducing an internal helical formation into a flexible tubular material |
US20030120257A1 (en) * | 2001-11-20 | 2003-06-26 | Houston John Graeme | Method for introducing an internal helical formation into a flexible tubular material |
US7968036B2 (en) | 2001-11-20 | 2011-06-28 | Tayside Flow Technologies Limited | Method for introducing an internal helical formation into a flexible tubular material |
US20030176516A1 (en) * | 2002-03-15 | 2003-09-18 | Greene, Tweed Of Delaware, Inc. | Cellular perfluoroelastomeric compositions, sealing members, methods of making the same and cellular materials for medical applications |
EP1560676A1 (en) * | 2002-10-25 | 2005-08-10 | Medinol Ltd. | Mandrel and method for making stents |
AU2003274666B2 (en) * | 2002-10-25 | 2008-10-23 | Medinol Ltd | Mandrel and method for making stents |
AU2003274666C1 (en) * | 2002-10-25 | 2009-04-02 | Medinol Ltd | Mandrel and method for making stents |
EP1560676A4 (en) * | 2002-10-25 | 2006-11-02 | Medinol Ltd | Mandrel and method for making stents |
WO2004037479A1 (en) | 2002-10-25 | 2004-05-06 | Medinol Ltd. | Mandrel and method for making stents |
US20070106373A1 (en) * | 2003-07-04 | 2007-05-10 | Tayside Flow Technologies Limited | Internal formation for a conduit |
US8454675B2 (en) | 2003-07-04 | 2013-06-04 | Tayside Flow Technologies Ltd. | Internal formation for a conduit |
WO2006136861A1 (en) * | 2005-06-24 | 2006-12-28 | Veryan Medical Limited | Artificial graft tubing |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2685454C (en) | Eptfe crimped graft | |
US4955899A (en) | Longitudinally compliant vascular graft | |
US4822361A (en) | Tubular prosthesis having a composite structure | |
USRE31618E (en) | Tubular organic prosthesis | |
US4173689A (en) | Synthetic polymer prosthesis material | |
EP0767684B1 (en) | Radially expandable polytetrafluoroethylene and expandable endovascular stents formed therewith | |
US5591222A (en) | Method of manufacturing a device to dilate ducts in vivo | |
US4713070A (en) | Porous structure of polytetrafluoroethylene and process for production thereof | |
CA1140704A (en) | Tubular organic prothesis and process for the production thereof | |
US5897587A (en) | Multi-stage prosthesis | |
US4657544A (en) | Cardiovascular graft and method of forming same | |
US5756035A (en) | Method of making an access graft and a vascular prosthesis | |
US9814560B2 (en) | Tapered implantable device and methods for making such devices | |
US3337673A (en) | Uniformly corrugated prosthesis and process of making same | |
JPS62152470A (en) | Tubular organ prosthetics | |
EP0269449A2 (en) | Porous flexible radially expanded fluoropolymers and process for producing the same | |
US3938524A (en) | Compliant mandrel and mandrel assembly for growing graft tubes | |
WO1998019632A1 (en) | Artificial tubular body organ grafts | |
EP0807425B1 (en) | Making an access graft | |
WO1993002637A1 (en) | Vascular prosthesis | |
JP2009515614A (en) | Method for producing a hollow cross-section based on a cross-linked gelatinous material and an implant in the form of a hollow cross-section | |
JPS6051912B2 (en) | catheter tube | |
EP0928604A1 (en) | Stent | |
JPS62152467A (en) | Method for manufacturing tubular organ prosthesis material | |
JPH0261260B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: POLYMEDICA INDUSTRIES, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:UNDERWOOD, CHRISTOPHER JOHN;CHARLESWORTH, DAVID;CHIAN, KERM SIN;REEL/FRAME:008072/0576;SIGNING DATES FROM 19960617 TO 19960719 |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
AS | Assignment |
Owner name: NERVATION LIMITED, GREAT BRITAIN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CARDIOTECH INTERNATIONAL INC.;REEL/FRAME:012059/0777 Effective date: 20010509 |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
CC | Certificate of correction | ||
AS | Assignment |
Owner name: LEMAITRE UK ACQUISTION LLC, MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CREDENT LIMITED;REEL/FRAME:015942/0288 Effective date: 20030429 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
FEPP | Fee payment procedure |
Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20100526 |